Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types

Overview of attention for article published in Therapeutic Drug Monitoring, April 2004

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

policy: 1 policy source
patent: 2 patents

wikipedia: 8 Wikipedia pages

Citations

dimensions_citation: 127 Dimensions

Readers on

mendeley: 63 Mendeley

Summary Policy documents Patents Wikipedia Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances

Cited by European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) on 02 Jan 2009

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the leading authority on illicit drugs in the European Union.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.